Form EFFECT AMICUS THERAPEUTICS,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 29, 2026 |
| Accession Number: | 0001140361-26-016986 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Clearway Energy names new CFO and controller amid leadership shuffle
- Apeing’s $0.0004 Presale Nears Its Next Stage: 410M+ Sold as Traders Eye the Next Big Crypto Beyond ETH and AVAX
- PureHealth Research Highlights Targeted Nutritional Support for Digestive Comfort With Acid Reflux Supplements
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share